These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 25468170)

  • 41. Psychotherapy for depression in older veterans via telemedicine: a randomised, open-label, non-inferiority trial.
    Egede LE; Acierno R; Knapp RG; Lejuez C; Hernandez-Tejada M; Payne EH; Frueh BC
    Lancet Psychiatry; 2015 Aug; 2(8):693-701. PubMed ID: 26249300
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial.
    Engert A; Haverkamp H; Kobe C; Markova J; Renner C; Ho A; Zijlstra J; Král Z; Fuchs M; Hallek M; Kanz L; Döhner H; Dörken B; Engel N; Topp M; Klutmann S; Amthauer H; Bockisch A; Kluge R; Kratochwil C; Schober O; Greil R; Andreesen R; Kneba M; Pfreundschuh M; Stein H; Eich HT; Müller RP; Dietlein M; Borchmann P; Diehl V; ; ;
    Lancet; 2012 May; 379(9828):1791-9. PubMed ID: 22480758
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vertebral osteomyelitis due to Fusobacterium species: report of three cases and review of the literature.
    Le Moal G; Juhel L; Grollier G; Godet C; Azais I; Roblot F
    J Infect; 2005 Aug; 51(2):E5-9. PubMed ID: 16038751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study.
    Clotet B; Feinberg J; van Lunzen J; Khuong-Josses MA; Antinori A; Dumitru I; Pokrovskiy V; Fehr J; Ortiz R; Saag M; Harris J; Brennan C; Fujiwara T; Min S;
    Lancet; 2014 Jun; 383(9936):2222-31. PubMed ID: 24698485
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial.
    Hill LF; Clements MN; Turner MA; Donà D; Lutsar I; Jacqz-Aigrain E; Heath PT; Roilides E; Rawcliffe L; Alonso-Diaz C; Baraldi E; Dotta A; Ilmoja ML; Mahaveer A; Metsvaht T; Mitsiakos G; Papaevangelou V; Sarafidis K; Walker AS; Sharland M;
    Lancet Child Adolesc Health; 2022 Jan; 6(1):49-59. PubMed ID: 34843669
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial.
    Zhu AX; Park JO; Ryoo BY; Yen CJ; Poon R; Pastorelli D; Blanc JF; Chung HC; Baron AD; Pfiffer TE; Okusaka T; Kubackova K; Trojan J; Sastre J; Chau I; Chang SC; Abada PB; Yang L; Schwartz JD; Kudo M;
    Lancet Oncol; 2015 Jul; 16(7):859-70. PubMed ID: 26095784
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pyogenic vertebral osteomyelitis: identification of microorganism and laboratory markers used to predict clinical outcome.
    Yoon SH; Chung SK; Kim KJ; Kim HJ; Jin YJ; Kim HB
    Eur Spine J; 2010 Apr; 19(4):575-82. PubMed ID: 19937064
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The clinical use of erythrocyte sedimentation rate in pyogenic vertebral osteomyelitis.
    Carragee EJ; Kim D; van der Vlugt T; Vittum D
    Spine (Phila Pa 1976); 1997 Sep; 22(18):2089-93. PubMed ID: 9322319
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Susceptibility Pattern of Microorganisms Isolated by Percutaneous Needle Biopsy in Nonbacteremic Pyogenic Vertebral Osteomyelitis.
    Desoutter S; Cottier JP; Ghout I; Issartel B; Dinh A; Martin A; Carlier R; Bernard L;
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7700-6. PubMed ID: 26438497
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial.
    Schilsky ML; Czlonkowska A; Zuin M; Cassiman D; Twardowschy C; Poujois A; Gondim FAA; Denk G; Cury RG; Ott P; Moore J; Ala A; D'Inca R; Couchonnal-Bedoya E; D'Hollander K; Dubois N; Kamlin COF; Weiss KH;
    Lancet Gastroenterol Hepatol; 2022 Dec; 7(12):1092-1102. PubMed ID: 36183738
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women.
    van Nieuwkoop C; van der Starre WE; Stalenhoef JE; van Aartrijk AM; van der Reijden TJ; Vollaard AM; Delfos NM; van 't Wout JW; Blom JW; Spelt IC; Leyten EM; Koster T; Ablij HC; van der Beek MT; Knol MJ; van Dissel JT
    BMC Med; 2017 Apr; 15(1):70. PubMed ID: 28366170
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Image-guided percutaneous disc sampling: impact of antecedent antibiotics on yield.
    Agarwal V; Wo S; Lagemann GM; Tsay J; Delfyett WT
    Clin Radiol; 2016 Mar; 71(3):228-34. PubMed ID: 26703118
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microbiologically and clinically diagnosed vertebral osteomyelitis: impact of prior antibiotic exposure.
    Kim CJ; Song KH; Park WB; Kim ES; Park SW; Kim HB; Oh MD; Kim NJ
    Antimicrob Agents Chemother; 2012 Apr; 56(4):2122-4. PubMed ID: 22232286
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of pyogenic postoperative and native vertebral osteomyelitis.
    Kim UJ; Bae JY; Kim SE; Kim CJ; Kang SJ; Jang HC; Jung SI; Song KH; Kim ES; Kim HB; Park WB; Kim NJ; Park KH
    Spine J; 2019 May; 19(5):880-887. PubMed ID: 30500465
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic outcomes of hematogenous vertebral osteomyelitis with instrumented surgery.
    Park KH; Cho OH; Lee YM; Moon C; Park SY; Moon SM; Lee JH; Park JS; Ryu KN; Kim SH; Lee SO; Choi SH; Lee MS; Kim YS; Woo JH; Bae IG
    Clin Infect Dis; 2015 May; 60(9):1330-8. PubMed ID: 25663159
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Non-contiguous multifocal vertebral osteomyelitis caused by Serratia marcescens.
    Lau JX; Li JY; Yong TY
    Mod Rheumatol; 2015 Mar; 25(2):303-6. PubMed ID: 24533544
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Short postsurgical antibiotic therapy for spinal infections: protocol of prospective, randomized, unblinded, noninferiority trials (SASI trials).
    Betz M; Uçkay I; Schüpbach R; Gröber T; Botter SM; Burkhard J; Holy D; Achermann Y; Farshad M
    Trials; 2020 Feb; 21(1):144. PubMed ID: 32028985
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pyogenic vertebral osteomyelitis of the elderly: Characteristics and outcomes.
    Courjon J; Lemaignen A; Ghout I; Therby A; Belmatoug N; Dinh A; Gras G; Bernard L;
    PLoS One; 2017; 12(12):e0188470. PubMed ID: 29206837
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Six-week versus twelve-week antibiotic therapy for nonsurgically treated diabetic foot osteomyelitis: a multicenter open-label controlled randomized study.
    Tone A; Nguyen S; Devemy F; Topolinski H; Valette M; Cazaubiel M; Fayard A; Beltrand É; Lemaire C; Senneville É
    Diabetes Care; 2015 Feb; 38(2):302-7. PubMed ID: 25414157
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ACP Journal Club. 6 weeks of antibiotics was noninferior to 12 weeks for clinical cure in pyogenic vertebral osteomyelitis.
    Zervou FN; Zacharioudakis IM; Mylonakis E
    Ann Intern Med; 2015 May; 162(10):JC7. PubMed ID: 25984880
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.